Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
9 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00004436 | Randomized Study of Hormonal Regulation of Infantile Hemangioma | completed | N/A | 30 | FDA Office of Orphan Products DevelopmentFED | 0 | Mar 25, 2015 | clinicaltrials |
| NCT00004437 | Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2 | completed | Phase 2 | — | FDA Office of Orphan Products DevelopmentFED | 0 | Mar 25, 2015 | clinicaltrials |
| NCT00004832 | Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome | completed | N/A | 26 | FDA Office of Orphan Products DevelopmentFED | 0 | Mar 25, 2015 | clinicaltrials |
| NCT00004941 | Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease | completed | Phase 3 | 94 | FDA Office of Orphan Products DevelopmentFED | 0 | Mar 25, 2015 | clinicaltrials |
| NCT00029328 | Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation | completed | Phase 1 / Phase 2 | 15 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00029900 | ADI-PEG in Patients With Metastatic Melanoma | completed | Phase 1 | 15 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00030043 | An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors | completed | Phase 1 | 10 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00056992 | Testing of ADI-PEG in Hepatocellular Carcinoma | completed | Phase 2 | 34 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00285350 | Mycophenolate Mofetil in Myasthenia Gravis | completed | Phase 3 | 80 | FDA Office of Orphan Products DevelopmentFED | 0 | Mar 25, 2015 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials